Amanote Research

Amanote Research

    RegisterSign In

New Alternatives in the N.H.S. II. What Advances in Treatment Can We Afford? Criteria for Introducing Technical Advance.

BMJ
doi 10.1136/bmj.4.5940.327
Full Text
Open PDF
Abstract

Available in full text

Date

November 9, 1974

Authors
P Rhodes
Publisher

BMJ


Related search

New Advances in the N.H.S. II. What Advances in Treatment Can We Afford? What Information Do Doctors Need?

BMJ
1974English

Can We Afford Open-Ended ICU Care? Yes We Can, but ...

Critical Care
Critical CareIntensive Care Medicine
2010English

Can We Afford Screening for Neural Tube Defects?

BMJ
1985English

Remedies for the Obesity Epidemic: Can We Afford Them? Do We Want Them?

Online Journal of Health Ethics
2004English

Biomarkers Predicting Antidepressant Treatment Response: How Can We Advance the Field?

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2013English

We Have a New Treatment, but You Can't Afford It

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2006English

News From ASH 2018—how Can We Afford Innovation in the Future?

Memo - Magazine of European Medical Oncology
OncologyHematology
2019English

Antimicrobial Stewardship - Can We Afford to Do Without It?

British Journal of Clinical Pharmacology
Pharmacology
2015English

Can We Afford to Neglect Forest Insect Outbreaks

Forestry Chronicle
Forestry
1935English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy